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(p4161 International, Multi-Center Investigation of 
LB20304, a New Fluoronaphthyridone 
R. Frei ' , A. Hohl ' , V Punter', A. von Graevenik ', C. Knapp ', 
J. Washington ', D. Johnson ', R. Jones '. 'Bacteriology Laboratory, 
University Cliniq Busel, Switzerland, ' Clinical Microbiology Laboratory, 
Institute $Medical Microbiology, Zurich, Switzerland, 3Department of 
Clinical Pathology, The Cleveland Clinic Foundation, Cleveland, OH, 
USA, 4Department $Pathology, University o f  Iowa College o f  Medicine, 
Iowa City, IA, U S A  
Objective: To evaluate the in vitro activity and spectrum of a new 
fluoronaphthyridone, LB20304, compared to six other quinolones 
in four laboratories. 
Methods: A total of 379 strains were tested, using NCCLS ap- 
proved microtiter MIC tesang. 
Results: LB20304 exhibited a spectrum and activity closest to 
that of trodoxacin and chnafloxacin versus Gram-positive cocci, 
but was less active than ciprofloxacin against Enterobacteriaceae and 
Pseudomonas aeruginosa. The rank order of spectra (% lnhibited at 
- <1 mg/l) favored clinafloxacin (92%) > LB20304 = trodoxacin 
(87%) > sparlloxacin (80%). Overall spectrum among the clinically 
adable  drugs favored ciprofloxacin = ofloxacin (80%) > fleroxacin 
(76%). Agamst Sfenohophomonus maltophilia, clinafloxacin demon- 
strated the hghest activity (MIGO, 0.5 mg/l). No sigdicant dif- 
ferences in activity were noted between centers. 
Conclusion: LB20304 appears to possess in vitro potency and 
spectrum characteristics comparable to clinafloxacin, trodoxacin 
and spadoxacin, i.e., other promising new quinolones. 
Does an In Viiro Synergism Between Newer 
Fluoroquinolones and Gentamicin (GM) on 
Enterncoccus faecalis May Exist? A Preliminary 
Report 
E.J. Giamarellos-Bourboulis, H. Sambatakou, Z. Chrysouli, 
H. Giamarellou. 1" Dept. Prop. Med., Athens Med. Srhool, Greece 
Objective: The in vim synergy between two fluoroquinolones, 
DU-6859a (Dv) and trovofloxacin (TR), and GM on E.&ecalis. 
Methods: Nine isolates resistant to both DU and TR (MIC: 8 to 
>64 pg/ml) possessing an MIC to GM >16 p g / d  were exposed 
over time to 2 p g / d  of DU or TR and 10 p g / d  of GM i.e. 
concentrations equal to their mean serum levels. Tubes of a 10 ml 
final volume and a 5 x lo5 cfu/ml overnight inoculum were applied 
and bacterial growth was measured at 0 time, 2, 4, 6 and 24 h of 
growth at 37°C. AU isolates were exposed to DU + GM and seven to 
'IR + GM. A total of 50 killing-curves was performed and synergy 
was defined as any 2 2  loglo decrease of viable cell counts compared 
to the most active single agent. 
Results: Synergy was found for two (22.2%) and 0 isolates at 4 h; 
for two (22.2%) and one (14.3%) at 6 h; and for five (55.6%) and two 
(28.6%) at 24 h by DU and GM and by TR and GM respectively. 
Synergy by DU and GM at 24 h involved two hghly streptomycin 
and gentanicin resistant isolates (MIC >lo00 pg/ml) while two 
ampicillin-resistant isolates dld not express synergy. 
Conclusions: Even though further in vitro observations are nec- 
essary, the combination of DU and GM might be promising for 
multiresistant E. faecalis infections. 
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I P418 1 Vancomycin-Sensitive and Resistant 
Enterococcal Nosocomial Bacteremia in Cancer 
Patients 
S .  Spanik, F! Pichna, J. Trupl, A. Kunova, K. Kralovicova, 
A. Krchnakova, E. Kukuckova, E. Oravcova, A. Demitrovicova, 
I. Krupova, K. Stopkova, S. Grausova, J. Svec, V. Krcmery, Jr., 
F! Pichna. St. Elizabeth Cancer Institute, University o f  Bratislava, 
Postgrad. Med. School, Sfom& Republic, National Cancer Institute, 
University o f  Tmava, Slova& Republic 
A retrospective analysis of 68 episodes of Enterococcal bacteremia 
in 67 cancer patients within 6 years was performed. 60 episodes 
(88.2%) were due to vancomycin-sensitive Enferococrus (E.) faecalis 
and 8 (1 1.7%) due to (vancomycin resistant) E. foecium. Incidence of 
enterococcal bacteremia increased from 1.6 per 1000 admissions in 
1989 to 14.6/1000 a b s i o m  in 1994, however the proportion of 
vancomycin-resistant bacteremia was low and relatively stable despite 
15x increase of vancomycin consumption in 1994 in comparison 
to 1989. Central venous catheter insertion (76.4%), previous ther- 
apy with cephalosporines (54.4%), vancomycin (58.8%), previous 
prophylaxis with quinolones (41.2%), and acute leukemia (39.7%) 
appeared most kquently among bacteremias. More than one half 
of cases of bacteremia were polymicrobial. Comparing both groups, 
there was no difference in clinical course and outcome between 
E. f.ecafis (60 patients) and E.  fecium (8 patients). Previous therapy 
with an aminoglycoside, or breakthrough bacteremia were sigdicant 
more hquently associated vancomycin-resistant E. faecium than with 
vancomycin-sensitive E.fecafis. Mortahty was s d a r  in both groups 
- 12.5% in E.fmcalis and 18.3% in E.fnecium bacteremia respectively. 
[=I National Surveillance Study on Glycopeptide 
Resistant Enterococci (GRE) in Belgium: Report 
of the First Semester of 1996 
B. Gordts ', H. Van Landuyt', M. Ieven', F! Vandamme', 
H. Goossens2 for the GOSPIWGDEPIH Group. 'A.Z. St.Jan, 
Bnqge, Belgium, 'University o f  AnmeT, Belgium 
G m  have become major nosocomial pathogens in the U.S.A., and 
also emerged in Europe. In Belgium, sporadic infections but no 
epidemic with GRE were described before 1996, although asymp- 
tomatic carriers were frequently found. In order to develop an ad- 
equate preventive strategy, we set up a continuous national surveil- 
lance study on GRE from Jan. 1, 1996 on. Suay-four Beban labo- 
ratories agreed to collaborate. During the l th and 2nd trimester of 
96, respect. 30 and 34 laboratories send their local epidemiological 
data firom which we could calculate that the incidence of Entero- 
coccus spp. in chical samples was 2.5%. GRE were reported h m  
15/281,000 samples (0.005%), (0.22% of all enterococci). AU but 1 
patient had been admitted to a hospital. GRE infection occurred in 
1.5/10,000 hospital admissions. Twelve lab's send us 58 enterococci 
presumably resistant to glycopeptides. Only 29 (50%) proved to be 
G m :  5 E.faecalic (17%). 22 E. foecium (76%), 1 E. gallinarum and 1 
E. cusselfivus. The majority of strains demonstrated the mnA geno- 
type (90%) in PCR. One strain was vanB positive, and 2 strains mnC. 
DNA macrorestriction analysis (Smal) showed that 72% of the iso- 
lates were genomically unrelated. Four pairs of strains had identical 
PFGE types. Half of those were recovered €-om one hospital, but the 
epidemiological relation of the other 4 strains remains unclear. The 
preliminary results of this national study demonstrate that G m  in- 
fections are still very rare in Belgium, occur sporadlcally, but mostly 
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in hospitalized patients. Although rare, nosocomial clusters seem to 
emerge. 
The In-Viiro Antimicrobial Susceptibility of 
Enterococcus spp. Isolated from Blood 
A. King, WR. Gransden, G.L. French, I. Phillips. UMDS Guy’s and 
St. Thomas’s Hospifals, London, UK 
Objective: To study the evolution of antibiotic resistance in entero- 
cocci. 
Methods: All enterococci isolated from blood at St. Thomas’ 
Hospital since 1969 (319 isolates) and at Guy’s Hospital in 1995-96 
(134 isolates) have been studied for susceptibility to ampicillin, ery- 
thromycin, chloramphenicol, aminoglycosides and vancomycin. Sus- 
ceptibility to quinupristin/da&opristin (q/d) and, for selected resis- 
tant isolates, to two glycylcyclines was tested during 1996. MICs 
were determined in IsoSensitest broth in microtitre trays with an 
MIC 2000 (Dynatech) and for the glycylcyclines by IsoSensitest agar 
aution. The inodum size for aII tests was lo4 cfu. 
Results Ampicillin resistance was seen only in E.  faecium (80% 
resistant): no p-lactamase producers were detected. Erythromycin 
resistance rose from 13% in the 1970s to 44% in the 1990s and chlo- 
ramphenicol resistance from < 10% prior to 1985 to 25%. High-level 
streptomycin resistance rose steadily from 6% in 1970 to 45% in 1996 
and high-level gentamicin resistance, first seen in 1986, reached 30% 
by 1990. Vancomycin resistance, seen in <1% of isolates h m  St. 
Thomas’ Hospital during the past 2 years was found in 16% of iso- 
lates b m  Guy’s Hospital mostly in E.  fiecium. All isolates of E .  
faecium were sensitive to q/d but it was less active against other ente- 
rococci. The glycylcyclines were active against all enterococci tested. 
Conclusion: Enterococci have become increasingly resistant to 
antibiotics over the past 30 years but q/d is currently active against 
all E.  faen‘um and two experimental glycylcyclines against all entero- 
cocci. 
I P42 1 I Characterization of 28 Strains of 
Vancomycin-Resistant Enterococci 
N. Liasine I ,  R. Frei ’, I. Jan 
Hospital, Gem, Switzerland, U n i m i t y  Hospital, Basel, Switzerland 
Objectives: To determine glycopeptide-resistance genotypes and 
to type Vancomycin-Resistant Enterococci (VRE) isolated in our 
laboratory by Pulsed-Field Gel Electrophoresis (PFGE). 
Methods: 28 strains of VRE isolated h m  15 intestinal car- 
rier patients and from 9 infected patients, previously identified by 
API 20 STREP were tested in a single multiplex PCR assay based 
on specific detection of genes encoding D-alanine:D-aIanine lig- 
ases (uanC1, uanC2-C3, efadl and efedl) and genes encoding related 
glycopeptide resistance enzymes ( w d  and van@. Molecular typing 
was made by PFGE. MICs for vancomycin and teicoplanin were 
determined by the E-test. 
Results: 15 strains were idenhfied as E.faecium, 8 as E.  gallinanrm, 
4 as E.fiecaZis and one as E .  durans. K a d  genotype was the most 
prevalent glycopeptide-resistant genotype in both intestinal carriers 
(10115) and in infected patients (6/9). Three strains of the vanB 
genotype (two E.  gallinarum and one E.  faecium) were isolated. All 
v a d  genotype strains were highly resistant to both vancomycin and 
teicoplanin except 3 strains which were susceptible to teicoplanin 
according NCCLS criteria. By PFGE, s& or identical band- 
ing patterns of an E.  faecium with mnA genotype were found in 5 
different patients for which the epidemiological link could not be 
elucidated. 
R. Auckenthaler ‘ Uniwrsity 
Conclusion: The majority, of VRE isolated in Geneva belonged 
to the v a d  genotype, whenas uanB genotype was less prevalent. 
VRE strains were not related except a cluster of similar strains ob- 
served in 5 patients. Atypical strains of u a d  genotype susceptible 
to teicoplanin suggest that the phenotype not always predicts the 
genotype and vice versa. 
1 P422 I The Prevalence of Colonization with High-Level 
Aminoglycoside Resistant and 
Vancomycin-Resistant Enterococci (VRE) among 
Hospitalized Patients in Turkey 
M. Ekti, A. Eskitiirk, G. Culha, V Korten. Marmara University 
School $Medicine, Istanbul, Turkey 
To assess the prevalence of fecal carriage of lugh level gentam- 
icin-resistant (HLGR), high level streptomycin-resistant W R ) ,  
and VRE in a 270 bed teaching hospital, we obtained rectal swab 
cultures h m  45 patients within 48 houn of admission to medi- 
cal ICU and weekly thereafter. A point prevalence survey was also 
performed in 35 medical ward (MW) patients who has been taken 
vancomycin at least one week and in 20 healthy volunteers (HV) not 
exposed to antibiotics or associated with medical care. Afrer 24 hours 
enrichment in enterococcosd broth, the samples were plated onto 
enterococcosel agar with or without 25 p g / d  of vancomycin, 500 
kg/ml of gentamicin or 1000 pg/d of streptomycin. Five colonies 
grown on agars were identified using Facklam-Collins scheme. All 
samples contained enterococci except 8 from MW patients receiv- 
ing vancomycin. Overall, 10 of 45 (22%) ICU patients, 12 of 35 
(34%) MW patients and 1 of 20 HV were found to be colonized 
with HLSR enterococci. One of 45 ICU patients, 7 of 35 (20%) 
MW patients and none of the HV were found to be colonized with 
HLGR enterococci. The only HLGR isolate and 5 of 10 HLSR 
isolates were acquired during ICU s q .  No enterococcal infection 
was noted None of the rectal samples nor the samples from two 
main sewage treament plants in Istanbul revealed VRE. 
Colonization with HLGR enterococci was common, but VRE 
colonization could not be found in h o s p i b d  patients and in 
healthy Volunteers in contrast to reports from many European coun- 
tries. 
Vancomycinresistant Enterococci in Austria 
E Allerberger I ,  C. Lass-Florl 
E. Presterl 
Innsbnuk, Grar and Vienna, Austria, 2Robert Koch-Insh’tut, Gennany 
Objectives: To characterize Austrian vancomycinresistant entero- 
cocci (VRE). 
Methods: Nine VRE and 5 vancomycin sensitive enterncocci 
(VSE) undenvent pheno and genotypical analysis: 5 E .  faecium iso- 
lates of 4 patients (the sole patients with VRE at the Univ.-Hosp. 
Innsbruck in 1994 and 1995!), glycopeptide sensitive isolates col- 
lected in Innsbruck in Febr. 1996 for epidemiological analysis, and 
enterococcus isolates from the university hospitals in Vienna and 
GraZ. 
Results: The pheno and genotypical analyses of all glycopep 
tide highly resistant E .  faecium and E.  faecalis isolates indicated the 
presence of VanA type. One E.  carseltpavus strain with intrinsic 
VanC-1 resistance showed characteristic constitutive low level resis- 
tance against Vancomycin and susceptibility to Teicoplanin. Geno- 
typing with macro-resmcaon analysis demonstrated that 3 VRE iso- 
lates and 2 VSE isolates of the 5 E.faecium specimens were identical. 
The two patients with VRE had been cared for at the same time in a 
surgical ICU, the two patients with VSE at a neurological ICU. The 
M.P. Dierich I ,  A. h c h l  I ,  
G. Haas I. Klare ’, W Witte *. ’ Unix-Hosp. 
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genotyping of E. &ecalis strains showed that two strains of the three 
VRE isolates exhibited identical patterns. Epidemiological investiga- 
tion &d not reveal a mode of transmission for this cluster. Two of 
the 8 patients with VRE died withm 60 days after isolation of the 
bacteria; the doctors in charge rejected enterococci as cause of death. 
Conclusions: The results of our study indicate oral Vancomycin 
application in humans as a primary cause of VRE in Austrian hos- 
pitals. In Austria approximately 66 kg Vancomycin, 20% of it given 
orally, are administered to patients per year. Only “small” quantities 
of the feed supplement Avoparcin are used in Aushia (approx. 18-20 
tons AVO TAN^ [active ingredient - ~O%]/year). 
of acquired-resistance: 77% were resistant to macrolides, 73% were 
HLKR, 8.7% were HLGR, one isolate was resistant to B-lactarmns 
and none to glycopeptides. 17 major DNA patterns were identified 
among the 25 typed HLGR isolates and 69 among 142 HLKR iso- 
lates. Two DNA patterns included 41 HLKR isolates from patients 
hospidzed in the 7 hospitals on the two periods and HLKR isolates 
from cheeses. 
Conclusion: Exogenous acquisition of HLKR Enterococcus by 
clonal dissemination with cheeses and patients as possible sources 
was fkquent in hospitalized patients in east France. 
I P424 I Resistant Enterococci in a State Clinical Hospital 
M. Bronk, A. Samet. Dept. of Clinical Bacterioloa, State Clinical 
Hospital iV’ 1. in Gdansk, Poland 
Objectives: Enterococci are important nosocomial pathogens and 
their growing resistance to antimicrobial agents is even more impor- 
tant from therapeutical point of view. 
Methods: Resistance to ampicillin, teicoplanin, vancomycin, 
gentamicin and streptomycin (Vitek GPS-IQ, bioMerieux, Vitek, 
Inc.) of 413 enterococcal strains was investigated. These strains (348 
E. faecalis, 65 E. faecium) were isolated from Merent clinical rnate- 
rials during two year periods (1995-1996). 167 (40.4%) s h a i n s  were 
isolated from pus, 162 (39.2%) from urine, 43 (10.4%) and 41 (9.9%) 
&om sputum and blood, respectively. 
N O 1  in Gdansk 
Results: 
Antibiotics M1C mg/l E.+rmlir E.+rdum 
Ampicillin 54 s 
Teicoplanm 58 S 
?32 R 
vlncomycin 54 s 
?32 R 
Gennmicin 5500 s 
A 0 0  R 
Strepromycln 52000 s 
>2000 R 
>I6 R 
316 (90.896) 10 (15.4%) 
32 (9.2%) 55 (84.6%) 
348 (1005b) 64 (98.5%) 
348 (lWs6) 64 (98.5%) 
142 (40.8%) 26 (40%) 
206 (59.2%) 39 (60%) 
97 (29.9%) 26 (40%) 
251 (72.1%) 39 (60%) 
- 1(1.5%) 
- 1 (1.5%) 
Conclusions: High level of aminoghcoside resistance among en- 
terococci is frequent. Vancornycin resistant E .  faecium (VRE) was 
isolated for the first time in our hospital. 
1 P425 I Rates of Resistance in Hospital €ntemcoccus 
Isolates: Gene or Clone Dissemination? 
D. Talon, V. Cdeaux, B. M&, M. Thouverez. Unit; 
d’tpidkmiologie molhculaire, Hdpitaljean Minjoz, Betaryon, France 
Objective: To assess the rates of resistance in hospital Enterococcus 
isolates in east France and the role of clonal dissemination. 
Methods: All clinical Entermom isolates were obtained during 
two one-month periods h m  patients hospitalized in 7 hospitals in 
east France. For all isolates, we determined the resistance by the 
Kirby-Bauer method and by E-Test method; the DNA patterns of 
multi-resistant isolates (erythromycin resistant and high-level resistant 
to kanamycin (HLKR) or to gentamycin (HLGR)) were analysed 
by pulsed-field gel electrophoresis after Smal macrorestriction and 
compared to DNA patterns of isolates b m  cheeses of the daily food 
ration of hospidzed patients. 
Results: The ntes of colonization/infection were 4.75 and 5.6% 
of admitted patients respectively for the two month-periods with 
two main sites: urinary tract 59.2% and surgical wound 21.7% of 
isolates. 86% of Entermoms isolates had one or several mechanisms 
I P426 I High Level Aminoglycoside Resistance in €. 
faecalis. Strain Diversity and AAC (B’)-APH (2”) 
Gene Conservation 
G.L. Daikos ’ , G. Bamias 
C. Kattamis ’. ‘Sismanoglion General Hospital, Athens, Greece, ’First 
Dpt. of Paediafrics Athens University, Athens, Greece 
The bifunctional enzyme gene AAC (6‘)-AF’H (2”) is the only 
known gene mediating high level aminoglycoside resistance (HLAR) 
in Enterocorcus jaecalis. 
Objectives: The purpose of the present study was to detect the 
AAC (6’)-APH (2”) gene in clinical isolates of E.&ecalis with HLAR 
and determine whether the nudeotide sequence of the gene is con- 
served among heterogeneous strains in our geographic region. 
MethoddResults Sixty four clinical isolates of E. jecalis ex- 
hibiting HLAR (MIC > 2000 pg/ml) were examined. The iso- 
lates had diverse DNA fingerprinting patterns as was determined 
by pulsed field gel electrophoresis of genomic DNA after dgestion 
with S d .  Aminoglycoside resistance was transferable into E.jaecah 
FA2-2 in 53 of 64 isolates. A polymerase chain reaction (PCR) based 
on the amplification of a 314 bp fixpent located in the gene region 
speclfylng both AAC (6‘) and APH (2”) activities u ~ a s  performed to 
detect the bifunctional enzyme gene. All the isolates gave a 314 bp 
PCR product. The amphfication products h m  all the isolates were 
hybridized with the AAC (6’)-APH (2”) intragenic gene carried in 
the SF815A plasmid. Sequencing of the 314 bp PCR products fiom 
5 isolates revealed identical nucleotide sequence. 
Conclusions: The bifunctional enzyme gene AAC (6’)-APH (2”) 
is hghly conserved among heterogeneous isolates of E. faecalis with 
HLAR in our geographic region. 
V. Syriopoulou ’, A. Botsonis, 
Susceptibility of Gram-Positive Pathogens to 
Teicoplanin and Vancomycin in Europe 
D. Felmingham I ,  I. Harding ’. ’ GR Micro Lid, VK, Thackelay’s 
Ltd, UK 
Objectives: to assess true rates of resistance to glycopeptides in 
Europe. 
Methods: Seventy laboratories in 9 European countries (Bel- 
gium, France, Germany, Italy, Netherlands, Portugal, Spain, Switzer- 
Stqph. nu- 2852 0.5 2 1 2 
CaqNegStaph 1444 1 4 2 2 
8 838 1 
91 2 8 S. kmolyrinrr 1 2 
shcptomvur spp. 0.25 0.5 1 770 0.13 
Enrommrr spp. 1695 0.25 0.5 1 4 
E. fo&um 183 0.5 4 1 8 
s. epidmnldir 2 2 
S. pnrumonior 289 0.13 0.13 0.5 0.5 
E. f.culir 1237 0.25 0.5 1 4 
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land, UK) each collected 100 consecutive Gram-positive isolates 
during 1995. Susceptibilities to teicoplanin (T) and vancomycin (V) 
were determined using agar dilution MICs (NCCLS). 
Results: are shown in the table. 
T gave similar MICs to V against S. aureus but two fold h h e r  
MICs against CNS, but was at least two fold more active than V 
against enterococci and streptococci. Resistance (NCCLS criteria) 
was found in 0% S. aureus, 0.6% (T) and 0.1% (V) CNS, 0.3% (T) 
and 0.9% (V) streptococci and 1.7% (T) and 2.3% (V) enterococci. 
9.3% of E.  faecium s t n i n s  were resistant to both T and V 
Conclusions: T is comparable with V against S. aureus, and gen- 
erally more active than V against streptococci. Resistance to gly- 
copeptides in enterococci should be monitored. 
I P428 1 In Viro Activity of Vancomycin and 17 Other 
Antibiotics on Gram-Positive Pathogens Isolated 
from lntravascular Devices in ltaly 
S. Manneh, M. Raggi, A. Marchese, E.A. Debbia, G.C. Schito for 
the Italian Vancomycin Study Group. Institute cfhficrobiology, 
University of Genoa, Italy 
During 1995 twenty clinical microbiology laboratories evenly 
distributed 'in Italy provided 1570 consecutive non repetitive 
gram-positive pathogens isolated h m  intravascular devices and 
blood to the center of Genoa where susceptibility of the 
strains to 18 selected antibiotics was assessed by MIC determi- 
nation based on NCCLS guidelines. The microorganisms stud- 
ied included 630 s. epidermidis, 401 s. aurarc, 72 S. haemolyti- 
m, 240 other coagulase-negative Staphylococci, 111 E. fie- 
calis, 25 E.  faecium, 30 other Enterococci, 49 Streptococci and 
12 Corynebacteria. Methi&-resistance was extremely preva- 
lent (62.4%) in this collection of Staphylococci. The in uitro 
activities of cephalothin, cefamandole, ceftriaxone, imipenem, 
gentamicin, netilmicin, tobramycin, erythromycin, tetracycline, 
trimethoprim/sulphamethoxazole, ciprofloxacin, chloramphenicol, 
clindamycin, rifampin, ampidm and streptomycin were highly vari- 
able depending on the species. Most of these compounds were de- 
void of useful activity on a large proportion of methicillin-resistant 
Staphylococci and Enterococci. Teicoplanin was inefficacious only 
against 8 S. hemolyticus (ll%), 2 E.  fnecalis (1.8%) and 1 E.  faecium 
(4%). Vancomycin sdered no limitations with the Staphylococci 
and showed the same level of resistance with the Enterococci. Over- 
all activity of the ghcopeptides, particularly, of vancomycin, against 
chically sigdicant gram-positive pathogens remains satisfactory in 
this country despite their extensive clinical usage. 
Methicillin-resistant staphlylococci 
(p429/ Eradication of an Epidemic Methicillin-Resistant 
Staphy/ococcus aureus Strain from a University 
Hospital 
I? K o h e n ,  M. Routamaa, T. Rossi, R. Peltonen, J. Oh, 
E. %tala, 0. Meurman, 0.-I? Lehtonen, J. Vuopio-Varkda. 
University of Tunhu and NationaZ Public Health Institute, Finland 
Objectives: To describe the control of an epidemic methi- 
cillin-resistant Staphylococcus aureuS (MRSA) strain in a Finnish um- 
versity hospital. 
Outbreak: Between March and August 1992,30 patients treated 
in our intensive care and hematologic units became colonized or 
infected with an epidemic MRSA strain. Only few clinical infections 
were noted. The index patient was referred to our hospital h m  an 
Italian hospital. The epidemic st ra in  was later isolated also h m  18 
members of the s d .  
Control measures: In the beginning of the outbreak, all MRSA 
patients were treated in side-rooms in contact isolation, but their 
contacts were neither screened nor isolated. Neither was the s d  
screened for MRSA. When new cases continuously occurred, all 
MRSA patien& were sent to the infectious disease unit to be nursed 
in strict isolation. Asymptomatic carriers were searched by taking 
colonization culpres h m  all known MRSA contacts, who were also 
isolated. Eradication treatment was given patient carriers, as well as 
to longterm carriers among the s d .  Intensive care and hematologic 
units were tempora@y closed. Thus, he outbreak was contained with 
the last new case found in February 93. 
Conclusions: Endcation of an epidemic MRSA st ra in  may suc- 
ceed even afcer an outbreak of 30 cases, if strict control measures are 
used. 
I P430 1 Spread of MRSA and MRSE in an Orthopedic 
Hospital 
I. Vingre, A. Zilevica. State Hospital .f EaumatoZogy and Orthopediu, 
Riga, Latvia 
Strains of methicillin resistant staphylococci which are resistant to 
most other antimicrobial agents have become a major problem in 
hospitals throughout the world. 
Objectives: To evaluate the prevalence and epidemiological situ- 
ation of Staphylococcus spread and their antibiotic susceptibility. 
Methods: Organisms were isolated h m  infected wounds, pu- 
rulent fluid h m  bursa or joint and h m  blood. The antibiotic 
susceptiblkty for all isolated strains was determined by disc dif€usion 
method. Oxacillin disc sensitivity testing was used to detect methi- 
cilline resistance. 
Results: During a four month period in 1996 we studed the 
incidence of surgical site infections in orthopedic surgery. A total 203 
microbial s t r a i n s  were isolated. The most fkequently reported isolates 
were S. aureus - 86 isolates and S. epidermidis - 68 isolates. In 63% 
cases monoinfections were registered in other cases association with 
gram negative pathogens E.  CoZi, Roteus, Klebsiella, Citmbader spp, 
Pseudomonas aemginosa was observed. 8 strains of S. aureus isolates 
(9.3%) were methlcillin-resistant, 22 strains of S. epidmidis (32%) 
were not susceptible to methiclllin. 
Conclusions: These results suggest that preventive measures for 
nosocomial infection and appropriate antibiotic therapy for the dis- 
eases are extremely necessary. 
Ip431) Resistancy Patterns of Staphylococci of DM 
Patients and Healthy Caniers 
L. Trapido, F? Rudenko, T. Mitt. MagdaZeena Hospital, TaZZinn, 
Estonia 
Objectives: To investigate the multiresistancy of strains of Stafylo- 
cocci. 
Methods: StaphyZococcus a u m  (Sa, N-67) and S t a p h y l m  epi- 
demidic (Se, N-54) were isolated h m  neurotrophic (N-54) and an- 
giotrophic (N-30) wounds of patients with Diabetes mellitus (DM, 
N-84). 48 strains of Sa were isolated h m  nares and throat (NT) 
of healthy persons. The prevalence of MRSA and MRSE was in- 
vestigated. Patients (N-84: 45 male, 39 female) had trophic wounds 
on legs. Antimicrobial susceptibility tests were performed with BBL 
Sensi-Discs (NCCLS Performance Standards). 
